International Patent: A SARS-COV-2 NUCLEOCAPSID PROTEIN-SPECIFIC VNAR ISOLATED FROM A NAÏVE PHAGE LIBRARY

GENEVA, June 24 -- CITY UNIVERSITY OF HONG KONG SHENZHEN RESEARCH INSTITUTE filed a patent application (CN2024/135498) for “A SARS-COV-2 NUCLEOCAPSID PROTEIN-SPECIFIC VNAR ISOLATED FROM A NAÏVE PHAGE LIBRARY”. With publication no. WO/2026/112937, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/10

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....